ELISA (EIA)
(Figure 1. Titration curves of anti-spike (SARS-CoV-2/South Africa variant) rabbit serum with EC50 of 4.6e-005.
96-well corning EILSA plate was coated with SARS-CoV-2 spike RBD at a concentration of 2 ?g/ml.)
COVID 19 Spike Protein (South Africa Variant) Neutralization Coronavirus Antibody | anti-COVID-19 antibody
Anti-Spike Protein (SARS-CoV-2/South Africa Variant) Rabbit Serum
Applications
Western Blot, ELISA, Neutralization Assay
Purity
Immunogen affinity purified IgG
Synonyms
COVID 19 Spike Protein (South Africa Variant) Neutralization Coronavirus; Anti-Spike Protein (SARS-CoV-2/South Africa Variant) Rabbit Serum; 2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spike Protein; South Africa Variant; Neutralization; anti-COVID-19 antibody
Specificity
Reacts with spike protein of SARS-CoV-2 and South Africa variants. Cross-reactivity to spike proteins from other coronavirus not tested.
Purity/Purification
Immunogen affinity purified IgG
Applicable Applications for anti-COVID-19 antibody
Western Blot (WB), ELISA (EIA), Neutralization Assay
Application Notes
Western blot (1:500-1:2000)
Immunogen
Full length spike protein of SARS-CoV-2 (South Africa variant) (GISAID Accession#: EPI_ISL_736980)
Preparation and Storage
Store at -20°C; Stable for 6-months from the date of shipment when kept at 4°C. Non-hazardous. No MSDS required.
ELISA (EIA)
(Figure 1. Titration curves of anti-spike (SARS-CoV-2/South Africa variant) rabbit serum with EC50 of 4.6e-005. 96-well corning EILSA plate was coated with SARS-CoV-2 spike RBD at a concentration of 2 ?g/ml.)
ELISA (EIA)
(Figure 1. Titration curves of anti-spike (SARS-CoV-2/South Africa variant) rabbit serum with EC50 of 4.6e-005.
96-well corning EILSA plate was coated with SARS-CoV-2 spike RBD at a concentration of 2 ?g/ml.)
Related Product Information for anti-COVID-19 antibody
Anti-spike protein antibody. Immunogen: SARS-CoV-2 South Africa variant spike protein.
The novel coronavirus (SARS-CoV-2), previously called 2019-nCoV, is a newly identified coronavirus causing the ongoing outbreak of atypical pneumonia in Wuhan China from late 2019.
The genome of SARS-CoV-2 has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike's receptor binding domain (RCB) of SARS-CoV-2 shares only 40% amino acid identity with other SARS-related coronaviruses.
Rabbit polyclonal anti-spike (SARS-CoV-2 South Africa variant) antibody, rabbit serum.
The novel coronavirus (SARS-CoV-2), previously called 2019-nCoV, is a newly identified coronavirus causing the ongoing outbreak of atypical pneumonia in Wuhan China from late 2019.
The genome of SARS-CoV-2 has 89% nucleotide identity with bat SARS-like-CoVZXC21 and 82% with that of human SARS-CoV. The phylogenetic trees of their orf1a/b, Spike, Envelope, Membrane and Nucleoprotein also clustered closely with those of the bat, civet and human SARS coronaviruses. However, the external subdomain of Spike's receptor binding domain (RCB) of SARS-CoV-2 shares only 40% amino acid identity with other SARS-related coronaviruses.
Rabbit polyclonal anti-spike (SARS-CoV-2 South Africa variant) antibody, rabbit serum.
Similar Products
Product Notes
The COVID-19 (Catalog #AAA434302) is an Antibody and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's COVID 19 Spike Protein (South Africa Variant) Neutralization Coronavirus can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), ELISA (EIA), Neutralization Assay. Western blot (1:500-1:2000). Researchers should empirically determine the suitability of the COVID-19 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "COVID 19 Spike Protein (South Africa Variant) Neutralization Coronavirus, Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
